Airway inflammation and mannitol challenge test in COPD

Respiratory Research

Volumn 12, Issue 1, 2011, Pages

  de Nijs, Selma B ^a   Fens, Niki ^a   Lutter, Rene ^a   Dijkers, Erica ^a   Krouwels, Frans H ^b   Smids Dierdorp, Barbara S ^a   van Steenwijk, Reindert P ^a   Sterk, Peter J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; SALBUTAMOL; SODIUM CHLORIDE; ANTIINFLAMMATORY AGENT; AUTACOID; DIAGNOSTIC AGENT; IL8 PROTEIN, HUMAN; INTERLEUKIN 8; MANNITOL; PEROXIDASE;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LIMIT OF DETECTION; LUNG FUNCTION TEST; MALE; MANNITOL CHALLENGE TEST; PRACTICE GUIDELINE; PROTEIN EXPRESSION; PROVOCATION TEST; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT INFLAMMATION; SENSITIVITY AND SPECIFICITY; SPIROMETRY; SPUTUM ANALYSIS; AGED; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HOSPITALIZATION; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; LOEFFLER PNEUMONIA; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; PNEUMONIA; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; SPUTUM; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; AGED; ANTI-INFLAMMATORY AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; MALE; MANNITOL; MIDDLE AGED; NETHERLANDS; PEROXIDASE; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EOSINOPHILIA; ROC CURVE; SEVERITY OF ILLNESS INDEX; SPUTUM; TREATMENT OUTCOME;

EID: 78651436464     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-11     Document Type: Article

References (33)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van WC, Zielinski J: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176: 532-555.
2. Djukanovic R, Sterk PJ, Fahy JV, Hargreave FE: Standardised methodology of sputum induction and processing. Eur Respir J Suppl 2002, 37: 1s-2s.
3. Pizzichini E, Pizzichini MM, Gibson P, Parameswaran K, Gleich GJ, Berman L, Dolovich J, Hargreave FE: Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 1998, 158: 1511-1517.
4. Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, Pavord ID: Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000, 356: 1480-1485.
5. Leigh R, Pizzichini MM, Morris MM, Maltais F, Hargreave FE, Pizzichini E: Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J 2006, 27: 964-971.
6. Siva R, Green RH, Brightling CE, Shelley M, Hargadon B, McKenna S, Monteiro W, Berry M, Parker D, Wardlaw AJ, Pavord ID: Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J 2007, 29: 906-913.
7. Cockcroft DW, Davis BE: Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol 2006, 118: 551-559.
8. Anderson SD, Brannan J, Spring J, Spalding N, Rodwell LT, Chan K, Gonda I, Walsh A, Clark AR: A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997, 156: 758-765.
9. Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B: The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res 2005, 6: 144.
10. Brannan JD, Anderson SD, Freed R, Leuppi JD, Koskela H, Chan HK: Nedocromil sodium inhibits responsiveness to inhaled mannitol in asthmatic subjects. Am J Respir Crit Care Med 2000, 161: 2096-2099.
11. Brannan JD, Koskela H, Anderson SD, Chan HK: Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology 2002, 7: 37-44.
12. Koskela HO, Hyvarinen L, Brannan JD, Chan HK, Anderson SD: Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma. Chest 2003, 124: 1341-1349.
13. Porsbjerg C, Brannan JD, Anderson SD, Backer V: Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin Exp Allergy 2008, 38: 43-50.
14. Leuppi JD, Tandjung R, Anderson SD, Stolz D, Brutsche MH, Bingisser R, Perruchoud AP, Surber C, Knoblauch A, Andersson M, Greiff L, Chan HK, Tamm M: Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept. Pulm Pharmacol Ther 2005, 18: 83-88.
15. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, Juniper EF, Malo JL: Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16: 53-83.
16. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Respir J 2005, 26: 319-338.
17. MacIntyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J: Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005, 26: 720-735.
18. O'Connor G: Analysis of Dose-Response Curves to Methacholine. An approach Suitable for Population Studies. Am Rev Respir Dis 1987, 136: 1412-1417.
19. in't Veen J, de Gouw HW, Smits HH, Sont JK, Hiemstra PS, Sterk PJ, Bel EH: Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J 1996, 9: 2441-2447.
20. Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE: Repeatability of inflammatory parameters in induced sputum of COPD patients. COPD 2007, 4: 321-329.
21. Bresser P, Out TA, van AL, Jansen HM, Lutter R: Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162: 947-952.
22. Out TA, Jansen HM, van Steenwijk RP, de Nooijer MJ, van de Graaf EA, Zuijderhoudt FM: ELISA of ceruloplasmin and alpha-2-macroglobulin in paired bronchoalveolar lavage fluid and serum samples. Clin Chim Acta 1987, 165: 277-288.
23. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide Am J Respir Crit Care Med 2005, 171: 912-930. 2005
24. Rutgers SR, Timens W, Tzanakis N, Kauffman HF, van der Mark TW, Koeter GH, Postma DS: Airway inflammation and hyperresponsiveness to adenosine 5'-monophosphate in chronic obstructive pulmonary disease. Clin Exp Allergy 2000, 30: 657-662.
25. Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M: Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 2003, 22: 491-496.
26. Brannan JD, Gulliksson M, Anderson SD, Chew N, Seale JP, Kumlin M: Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. Eur Respir J 2006, 27: 944-950.
27. Gulliksson M, Palmberg L, Nilsson G, Ahlstedt S, Kumlin M: Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells. Allergy 2006, 61: 1473-1479.
28. Fujimoto K, Yasuo M, Urushibata K, Hanaoka M, Koizumi T, Kubo K: Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 2005, 25: 640-646.
29. Grashoff WF, Sont JK, Sterk PJ, Hiemstra PS, de Boer WI, Stolk J, Han J, van Krieken JM: Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am J Pathol 1997, 151: 1785-1790.
30. Louis RE, Cataldo D, Buckley MG, Sele J, Henket M, Lau LC, Bartsch P, Walls AF, Djukanovic R: Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease. Eur Respir J 2002, 20: 325-331.
31. Andersson CK, Mori M, Bjermer L, Lofdahl CG, Erjefalt JS: Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 181: 206-217.
32. Wood LG, Powell H, Gibson PG: Mannitol challenge for assessment of airway responsiveness, airway inflammation and inflammatory phenotype in asthma. Clin Exp Allergy 2010, 40: 232-241.
33. Daviskas E, Anderson SD, Young IH: Inhaled mannitol changes the sputum properties in asthmatics with mucus hypersecretion. Respirology 2007, 12: 683-691.